Castanet-Tolosan, France

Johannes Lupker

This inventor holds 2 USPTO granted patents. Top assignee: Sanofi. Active years: 1995-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes Lupker. Retrieved from https://idiyas.com/inventor/johannes-lupker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Johannes Lupker

Introduction

Johannes Lupker is a notable inventor based in Castanet-Tolosan, France. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Lupker holds 2 patents, with his latest inventions focusing on urate oxidase activity proteins. One of his patents details a new urate oxidase activity protein, which includes a specific sequence (SEQ ID NO:1) that may be preceded by a methionine or exhibit substantial homology with this sequence. This invention also encompasses medicines containing this protein and the genetic engineering tools necessary for its production.

Career Highlights

Johannes Lupker is currently associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Lupker has collaborated with esteemed colleagues such as Daniel Caput and Pascual Ferrara. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.

Conclusion

Johannes Lupker's contributions to biotechnology and his innovative patents reflect his commitment to advancing medical science. His work continues to inspire future developments in therapeutic proteins and genetic engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…